Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» non-small cell lung cancer
non-small cell lung cancer
Bristol-Myers' latest PD-1 win could pave the path to earlier use
Fierce Biotech
Tue, 09/8/15 - 02:03 pm
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
Endocyte Announces Final Overall Survival Results From Phase 2b TARGET Trial in Non-Small Cell Lung Cancer Patients
Yahoo
Tue, 09/8/15 - 08:08 am
Endocyte
vintafolide
clinical trials
non-small cell lung cancer
Bristol-Myers' Opdivo snags FDA priority review for bigger lung cancer use
Fierce Pharma Marketing
Wed, 09/2/15 - 10:16 am
Opdivo
Bristol-Myers Squibb
FDA
priority review
non-small cell lung cancer
Eli Lilly's marginal cancer drug becomes Exhibit A in pricing debate
Fierce Biotech
Sat, 08/29/15 - 08:56 am
Eli Lilly
drug pricing
necitumumab
non-small cell lung cancer
After two deaths, Verastem defends safety of experimental cancer drug
Bizjournals.com
Wed, 08/26/15 - 08:43 pm
Verastem
VS-6063
non-small cell lung cancer
Hunting a fast approval in lung cancer, Roche racks up a positive PhII for 'atezo'
Fierce Biotech
Mon, 08/17/15 - 08:10 am
Roche
non-small cell lung cancer
atezolizumab
anti-PD-1 immunotherapy
FDA approves AstraZeneca's lung cancer drug as first-line treatment
Yahoo/Reuters
Mon, 07/13/15 - 05:05 pm
FDA
Iressa
AstraZeneca
non-small cell lung cancer
FDA support for Lilly cancer drug comes down to unmet needs vs side effects
BioPharma Dive
Sat, 07/11/15 - 10:34 am
FDA
Eli Lilly
necitumumab
non-small cell lung cancer
AstraZeneca Presents Positive Data on AZD9291 in First-Line EGFR Mutated Lung Cancer at ASCO 2015
Yahoo
Sun, 05/31/15 - 11:52 am
AstraZeneca
AZD9291
non-small cell lung cancer
A preview of the new lung cancer data Roche will debut at ASCO
BioPharma Dive
Fri, 05/15/15 - 09:34 am
non-small cell lung cancer
ASCO
Roche
Genentech
MPDL3280A
PDL-1 inhibitors
With Teva out, OncoGenex shrinks its PhIII lung cancer study
Fierce Biotech
Thu, 04/30/15 - 10:45 am
Teva Pharmaceutical
OncoGenex
non-small cell lung cancer
custirsen
Pfizer Receives U.S. FDA Breakthrough Therapy Designation For XALKORI® (crizotinib) For The Treatment Of Patients With ROS1-Positive Non-Small Cell Lung Cancer
Yahoo
Tue, 04/21/15 - 12:18 pm
Pfizer
Xalkori
non-small cell lung cancer
FDA
Merck's Keytruda shrinks lung cancer tumors, FDA approval sought
Yahoo/Reuters
Sun, 04/19/15 - 12:02 pm
Merck
Keytruda
lung cancer
FDA
non-small cell lung cancer
PDL-1 inhibitors
Bristol-Myers stops lung cancer trial after positive results
Marketwatch
Fri, 04/17/15 - 10:30 am
Opdivo
lung cancer
non-small cell lung cancer
Opdivo's survival benefit inspired FDA to act fast on NSCLC approval: Pazdur
Fierce Pharma
Mon, 03/9/15 - 02:52 pm
FDA
Bristol-Myers Squibb
Opdivo
non-small cell lung cancer
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Bidness Etc.
Tue, 02/3/15 - 09:07 am
FDA
breakthrough therapies
Genentech
anti-PD-L1
MPDL3280A
non-small cell lung cancer
Merck speeds up drug-submission plans for Hep C, lung cancer -WSJ
Yahoo/Reuters
Mon, 01/12/15 - 08:22 am
Merck
hepatitis C
non-small cell lung cancer
Keytruda
grazoprevir
elbasvir
AstraZeneca's (AZN) Iressa Accepted for Review in the U.S.
Yahoo/Zacks.com
Wed, 12/3/14 - 09:20 pm
AstraZeneca
Iressa
FDA
non-small cell lung cancer
Clovis taps GlaxoSmithKline to team up on lung cancer
Fierce Biotech
Tue, 11/18/14 - 11:51 am
Clovis
GSK
non-small cell lung cancer
Mekinist
rociletinib
Bristol immunotherapy shows promise in lung cancer trial
Yahoo/AP
Thu, 10/30/14 - 09:58 am
Bristol-Myers Squibb
non-small cell lung cancer
nivolumab
Pages
« first
‹ previous
…
12
13
14
15
16
17
18
19
20
…
next ›
last »